scPharmaceuticals Inc. to Present at the Jefferies 2018 Global Healthcare Conference

BURLINGTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. SCPH, a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer and Troy Ignelzi, chief financial officer, will present at the Jefferies 2018 Global Healthcare Conference at 2:00 p.m. ET on Wednesday, June 7, 2018, at the Grand Hyatt Hotel in New York, NY.

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the Company's website, www.scpharmaceuticals.com, and will be archived for ninety days. 

About scPharmaceuticals

scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that reduce healthcare costs and improve health outcomes.  The Company develops products for the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA.  For more information, please visit scPharmaceuticals.com.

Contacts:

Katherine Taudvin, scPharmaceuticals Inc.

781-301-6706

ktaudvin@scpharma.com

Christopher F. Brinzey, Westwicke Partners

339-970-2843

chris.brinzey@westwicke.com